The nation of Zimbabwe has rejected a substantial US healthcare agreement worth $367m (272 million pounds) over five years over the United States' insistence on sensitive biological samples.
This move became public after a official document dated December was leaked, revealing that Head of State Emmerson Mnangagwa deemed the arrangement was "unbalanced".
A government representative later stated that the United States was requesting health data for research and commercial gain but was unwilling to guarantee the resulting advantages from any future vaccines.
"We will now turn to the difficult and regrettable process of scaling back our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the United States had donated more than $1.9bn in health funding to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has appealed for further dialogue to reach a deal suitable to both sides so the country's critical HIV treatment initiative can proceed.
Wider Context
Zimbabwe's decision follows a similar case in Kenya, where a high court blocked a related health funding agreement after concerns were filed about the safety of citizens' medical information.
After resuming office last year, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.
The agency had overseen assistance for the US government, but Trump stated its expenditure was "wasteful" and his administration was pursuing direct bilateral deals to boost transparency and responsibility.
Based on statements, 16 African countries have to date signed similar agreements, representing more than $18.3bn in committed funds.
Details of the Declined Agreement
The money for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this collaboration might have yielded significant advantages for the people of Zimbabwe, particularly the 1.2 million presently receiving antiretroviral therapy through American-funded programmes," the Ambassador said.
However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".
"Our nation was requested to provide its genetic material and health information for a long time, without any equivalent guarantee of access to any medical innovations – such as new medicines or tests – that could result from that shared data," Mangwana explained.
"In essence, our country would provide the raw materials for medical research without any certainty that the resulting innovations would be accessible to our population if a future health crisis emerge."
National Interest and Global Health
He also said that the American exit from the global health body and its push of bilateral deals were disrupting systems previously established via the global organization.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme designed to deal with future global health emergencies.
"This framework is designed to ensure that when a country provides its information, the benefits – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the funds to create them."
These objections over the US deal "are not meant as anti-American sentiment," he added.
"We encourage further discussions with our American counterparts on how subsequent co-operation might be structured in a way that honours the sovereignty and dignity of both nations."
Medical Community Reaction
A leading public health body expressed it acknowledged the official position, but urged that talks should continue since much of the nation's HIV programmes were funded by international support.
"Where technical issues exist, including those involving data governance or implementation frameworks, these can frequently be addressed through technical clarification and negotiated safeguards," the group added.
The situation emphasises the continuing tensions between accepting crucial foreign assistance and safeguarding local interests in an ever more interconnected world.